TBX21 and asthma: More specifically, Tbet deficient T cells have been shown to drive airway IL-4 production and hyperreactivity in an asthma model and both IL-13 and IL-17A have been shown to be able to drive allergic airways disease in Tbet deficient mice [38–40].